rs140393851
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152490.5(B3GALNT2):c.410C>T(p.Ser137Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000148 in 1,614,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S137S) has been classified as Likely benign.
Frequency
Consequence
NM_152490.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B3GALNT2 | NM_152490.5 | c.410C>T | p.Ser137Leu | missense_variant | 4/12 | ENST00000366600.8 | NP_689703.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B3GALNT2 | ENST00000366600.8 | c.410C>T | p.Ser137Leu | missense_variant | 4/12 | 1 | NM_152490.5 | ENSP00000355559.3 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000259 AC: 65AN: 251216Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135748
GnomAD4 exome AF: 0.000142 AC: 208AN: 1461870Hom.: 0 Cov.: 32 AF XY: 0.000157 AC XY: 114AN XY: 727236
GnomAD4 genome AF: 0.000204 AC: 31AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74480
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 25, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 30, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2022 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 137 of the B3GALNT2 protein (p.Ser137Leu). This variant is present in population databases (rs140393851, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with B3GALNT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 452907). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 07, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.410C>T (p.S137L) alteration is located in exon 4 (coding exon 4) of the B3GALNT2 gene. This alteration results from a C to T substitution at nucleotide position 410, causing the serine (S) at amino acid position 137 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at